Inventor
LAUFFER DAVID J
US65 patents
⚠️ This page may combine multiple inventors who share the name “LAUFFER DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
43 patentsUS5756466AMay 26, 1998
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA191 citations99
US5716929AFeb 10, 1998
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA137 citations99
US5656627AAug 12, 1997
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA146 citations99
US9925188B2Mar 27, 2018
DNA-PK inhibitors and uses thereof
VERTEX PHARMA24 citations98
US9376448B2Jun 28, 2016
DNA-PK inhibitors
VERTEX PHARMA46 citations98
US5973111AOct 26, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA91 citations98
US5874424AFeb 23, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA141 citations98
US5847135ADec 8, 1998
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA159 citations98
US6350741B1Feb 26, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA112 citations97
US7872031B2Jan 18, 2011
c-MET protein kinase inhibitors
VERTEX PHARMA64 citations96
US6531474B1Mar 11, 2003
Inhibitors of caspases
VERTEX PHARMA62 citations96
US6423840B1Jul 23, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA40 citations96
US6420522B1Jul 16, 2002
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA72 citations96
US6258948B1Jul 10, 2001
Inhibitors of Interleukin-1β converting enzyme
VERTEX PHARMA42 citations96
US6204261B1Mar 20, 2001
Inhibitors of interleukin-1β Converting enzyme inhibitors
VERTEX PHARMA80 citations96
US6103711AAug 15, 2000
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA80 citations96
US6025147AFeb 15, 2000
Inhibitors of interleukin-1 β converting enzyme
VERTEX PHARMA57 citations96
US9592232B2Mar 14, 2017
DNA-PK inhibitors
VERTEX PHARMA24 citations94
US7288624B2Oct 30, 2007
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA48 citations94
US9878993B2Jan 30, 2018
DNA-PK inhibitors for treatment of cancer
VERTEX PHARMA10 citations92
US9359380B2Jun 7, 2016
DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9340557B2May 17, 2016
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA19 citations92
US9296701B2Mar 29, 2016
DNA-PK inhibitors
VERTEX PHARMA21 citations92
US7790713B2Sep 7, 2010
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA24 citations92
US7446199B2Nov 4, 2008
Compositions useful as inhibitors of protein kinases
VERTEX PHARMA29 citations92
US7314885B2Jan 1, 2008
Pyrrole compounds useful as kinase inhibitors
VERTEX PHARMA23 citations92
US6008217ADec 28, 1999
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA37 citations92
US7772366B2Aug 10, 2010
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA24 citations91
US10973830B2Apr 13, 2021
Substituted quinoxaline DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10786512B2Sep 29, 2020
DNA-PK inhibitors
VERTEX PHARMA3 citations84
US10501439B2Dec 10, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10442791B2Oct 15, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10391095B2Aug 27, 2019
DNA-PK inhibitors
VERTEX PHARMA5 citations84
US10258627B2Apr 16, 2019
DNA-PK inhibitors
VERTEX PHARMA4 citations84
US10076521B2Sep 18, 2018
DNA-PK inhibitors
VERTEX PHARMA7 citations84
US9987284B2Jun 5, 2018
Substituted benzooxadiazole DNA-PK inhibitors
VERTEX PHARMA5 citations84
US7728017B2Jun 1, 2010
Inhibitors of c-Met and uses thereof
VERTEX PHARMA8 citations83
US7169800B2Jan 30, 2007
Imidazole compositions useful as inhibitors of protein kinases
VERTEX PHARMA10 citations83
US7358273B2Apr 15, 2008
Inhibitors of caspases
VERTEX PHARMA5 citations74
US6974809B2Dec 13, 2005
Inhibitors of interleukin 1-β converting enzyme
VERTEX PHARMA5 citations74
US6426413B1Jul 30, 2002
Inhibitors of caspases
VERTEX PHARMA9 citations74
US6329365B1Dec 11, 2001
Inhibitors of interleukin-1β converting enzyme
VERTEX PHARMA5 citations74
US11059826B2Jul 13, 2021
Pteridinone compounds and uses thereof
VERTEX PHARMA3 citations72
WARNER LAMBERT CO
5 patentsUS5306718AApr 26, 1994
Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment
WARNER LAMBERT CO17 citations82
US5482938AJan 9, 1996
Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
WARNER LAMBERT CO9 citations74
US5464842ANov 7, 1995
Azabicyclo oxime and amine cholinergic agents and methods of treatment
WARNER LAMBERT CO9 citations74
US5318978AJun 7, 1994
Azabicyclo oxime and amine cholinergic agents and methods of treatment
WARNER LAMBERT CO11 citations74
US5346911ASep 13, 1994
Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
WARNER LAMBERT CO17 citations72
BATCHELOR MARK JAMES
1 patentLAUFFER DAVID J
1 patentShowing the top 50 of 65 patents by PatentIndex Score.